Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Albiglutide

Brand: Eperzan ®
NICE TA: 
Indication: Treatment of type 2 diabetes mellitus in adults to improve glycaemic control
Disease category: Endocrine system
Commissioning responsibility: CCG
PbR excluded: No

Background

Albiglutide is NOT recommended for use by the NHS in Lancashire. Data from the drug’s clinical trial programme indicate that albiglutide may not consistently achieve the beneficial metabolic response target set by NICE in Guideline 28 for continued prescribing of GLP‑1 agonists, defined as follows:
• a reduction of HbA1c by at least 11 mmol/mol [1.0%] and
• a weight loss of at least 3% of initial body weight in 6 months

Recommendation

LMMG recommendation: Black
Click here to find the definitions for the colour classifications

Reason for decision:  Not recommended for prescribing on the NHS in Lancashire

Supporting documents:

New Medicine Recommendation - Albiglutide And Dulaglutide (1.1 MiB)

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Black

Black

Black

Black

Black

Black